Robert A. Baffi
2019
Compensation breakdown
| Non-Equity Incentive Plan | $608,400 |
|---|---|
| Option Awards | $891,958 |
| Salary | $580,192 |
| Stock Awards | $4,390,232 |
| Other | $32,721 |
| Total | $6,503,503 |
Baffi received $4.4M in stock awards, accounting for 68% of the total pay in 2019.
Baffi also received $608.4K in non-equity incentive plan, $892K in option awards, $580.2K in salary and $32.7K in other compensation.
Rankings
In 2019, Robert A. Baffi's compensation ranked 1,523rd out of 13,971 executives tracked by ExecPay. In other words, Baffi earned more than 89.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,523 out of 13,971 | 89th |
Division Manufacturing | 547 out of 5,695 | 90th |
Major group Chemicals And Allied Products | 165 out of 2,194 | 93rd |
Industry group Drugs | 131 out of 1,880 | 93rd |
Industry Pharmaceutical Preparations | 98 out of 1,392 | 93rd |
Pay ratio
| Robert A. Baffi's Pay | $6,503,503 |
|---|---|
| Median Employee's Pay | $190,917 |
| Pay Ratio | 34to 1 |
In 2019, the annual total compensation of Robert A. Baffi was $6,503,503.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $190,917.
The ratio of Robert A. Baffi's pay to the pay of median employee was therefore 34 to one.
Baffi's colleagues
We found five more compensation records of executives who worked with Robert A. Baffi at BioMarin Pharmaceutical in 2019.
2019
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2019
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2019
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2019
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2019
Brian Mueller
BioMarin Pharmaceutical